Grupo Tumores Renales y Uroteliales
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublications en collaboration avec des chercheurs de Hospital de la Santa Creu i Sant Pau (1)
2022
-
Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study
European Urology Open Science, Vol. 40, pp. 38-45